# Carlos Vasconcelos

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carlos-vasconcelos/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,622 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 49 |
| i10-index | 109 |
| Last Known Institution | Universidade do Porto |
| OpenAlex ID | https://openalex.org/A5020805627 |
| ORCID iD | https://orcid.org/0000-0002-8073-5028 |
| Works | 298 |

## Researcher papers

- [2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology/)
- [Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients](https://scholariq.org/papers/antiphospholipid-syndrome-clinical-and-immunologic-manifestations-and-patterns/)
- [2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/2019-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria](https://scholariq.org/papers/the-international-criteria-for-behcet-s-disease-icbd-a-collaborative-study-of-27/)
- [Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide](https://scholariq.org/papers/immunosuppressive-therapy-in-lupus-nephritis-the-euro-lupus-nephritis-trial-a/)
- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients](https://scholariq.org/papers/morbidity-and-mortality-in-the-antiphospholipid-syndrome-during-a-10-year-period/)
- [Treat-to-target in systemic lupus erythematosus: recommendations from an international task force](https://scholariq.org/papers/treat-to-target-in-systemic-lupus-erythematosus-recommendations-from-an/)
- [Transancestral mapping and genetic load in systemic lupus erythematosus](https://scholariq.org/papers/transancestral-mapping-and-genetic-load-in-systemic-lupus-erythematosus/)
- [2021 DORIS definition of remission in SLE: final recommendations from an international task force](https://scholariq.org/papers/2021-doris-definition-of-remission-in-sle-final-recommendations-from-an/)
- [A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)](https://scholariq.org/papers/a-framework-for-remission-in-sle-consensus-findings-from-a-large-international/)
- [European consensus statement on the terminology used in the management of lupus glomerulonephritis](https://scholariq.org/papers/european-consensus-statement-on-the-terminology-used-in-the-management-of-lupus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Researcher university

- [Universidade do Porto](https://scholariq.org/institutions/universidade-do-porto/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.